Kirkeveien 166, Frederik Holsts hus (map)
Our research group seeks to generate evidence for improving health systems and global collective action for health. We examine priorities, strategies, and institutions critical to health systems strengthening, development assistance, and health security and transnational threats.
Risk of colorectal cancer in inflammatory bowel disease
– a multinational cohort study.
The project is aimed at optimizing resource-use within preventive health services for HPV-related disease, while simultaneously ensuring that these strategies continue to maximize health by reducing morbidity and mortality.
The EPoS-project is addressing one of the most important challenges in the prevention of colorectal cancer; the surveillance of patients that have had colorectal polyps removed (polypectomy). The study is conducted by leading researchers within gastroenterology, epidemiology and biostatistics from Europe and the United States.
The Research Group is conducting large randomized trials and observation studies to test and compare diagnostic and therapeutic clinical interventions in different areas of clinical medicine. The overarching goal is to find out what works and what does not. More than 300,000 patients are currently enrolled in studies run by the group.
Economic evaluation involves methods to assess the cost-effectiveness of treatments, procedures, diagnostics, screening practices, healthcare delivery routes and technologies in a broad sense.